Clincosm LogoSign in Get a demo

COVID-19

Showing NaN - NaN of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Russian Federation, United States (Placebo, Ruxolitinib)

Terminated
Has Results
  • COVID-19
  • Scottsdale, Arizona
  • +35 more
Jan 14, 2022

COVID-19 Trial in Philadelphia (Cyclosporine)

Completed
  • COVID-19
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 7, 2022

COVID-19 Trial in United States (Gimsilumab, Placebo)

Completed
Has Results
  • COVID-19
  • Phoenix, Arizona
  • +32 more
Dec 10, 2021

SARS-CoV-2, Covid-19 Trial in Philadelphia (Sirolimus 1 MG/ML, Placebo)

Withdrawn
  • SARS-CoV-2
  • Covid-19
  • Sirolimus 1 MG/ML
  • Placebo
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Dec 2, 2021

COVID-19 Trial in Philadelphia (Self-Benefit/Social Norm, Self-Benefit/No Social Norm, Other Benefit/Social Norm)

Completed
  • COVID-19
  • Self-Benefit/Social Norm
  • +3 more
  • Philadelphia, Pennsylvania
    Independence Blue Cross (IBX)
Nov 18, 2021

COVID-19 Trial in Worldwide (RDV, Placebo to Match RDV)

Terminated
Has Results
  • COVID-19
  • RDV
  • Placebo to Match RDV
  • Chandler, Arizona
  • +103 more
Nov 4, 2021

COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)

Completed
Has Results
  • COVID-19
  • Aurora, Colorado
  • +33 more
Oct 8, 2021

SARS-CoV-2/COVID-19 Prevalence Study

Completed
  • COVID-19
    • Aurora, Colorado
    • +14 more
    Sep 29, 2021

    COVID19, COVID-19, COVID Trial in United States (Pacritinib, Placebo)

    Terminated
    • COVID19
    • +2 more
    • Orange, California
    • +20 more
    Sep 23, 2021

    COVID-19 Trial in United States (Sarilumab, Placebo)

    Completed
    Has Results
    • COVID-19
    • Los Angeles, California
    • +61 more
    Sep 16, 2021

    COVID-19 Trial in United States (Acalabrutinib)

    Completed
    Has Results
    • COVID-19
    • Anniston, Alabama
    • +30 more
    Sep 8, 2021

    SARS-CoV-2-specific Immunity in Individuals Who Have Recovered

    Active, not recruiting
    • SARS-CoV-2
    • COVID-19
    • Sample collection
    • Birmingham, Alabama
    • +52 more
    Sep 3, 2021

    COVID-19 in Patients With Chronic Liver Diseases

    Completed
    • COVID-19
    • Chronic Liver Disease
    • Prospective Chart Review
    • Phoenix, Arizona
    • +22 more
    Aug 5, 2021

    COVID-19 Trial in United States (Remdesivir, Pulmozyme, IC14)

    Recruiting
    • COVID-19
    • Birmingham, Alabama
    • +18 more
    Jul 19, 2021

    COVID-19 Trial in El Centro, New York, Philadelphia (CPI-006, Standard of Care)

    Completed
    • COVID-19
    • El Centro, California
    • +2 more
    Jul 20, 2021

    COVID-19 Trial in Philadelphia (Convalescent Plasma)

    Completed
    • COVID-19
    • Convalescent Plasma
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Jun 3, 2021

    COVID-19 Trial in Philadelphia (Plasma Donation)

    Completed
    • COVID-19
    • Plasma Donation
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    May 7, 2021

    COVID-19 Trial in Philadelphia (Discontinuation of ARB/ACEI, Continuation of ARB/ACEI)

    Completed
    Has Results
    • COVID-19
    • Discontinuation of ARB/ACEI
    • Continuation of ARB/ACEI
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Apr 7, 2021

    COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)

    Completed
    Has Results
    • COVID-19
    • Anaheim, California
    • +183 more
    Jan 21, 2021

    COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)

    Completed
    Has Results
    • COVID-19
    • Anaheim, California
    • +182 more
    Dec 15, 2020

    COVID-19 Trial in Philadelphia (Hydroxychloroquine Sulfate 400 mg twice a day, Hydroxychloroquine Sulfate 600 mg twice a day,

    Terminated
    Has Results
    • COVID-19
    • Hydroxychloroquine Sulfate 400 mg twice a day
    • +3 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Dec 8, 2020